rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-8-2
|
pubmed:abstractText |
Treatment of Alzheimer's disease (AD) with cholinesterase inhibitors carries a theoretical risk of precipitating bradycardia. Though syncope occurs in patients with AD, its aetiology is unclear. The aim of this study was to determine the causes of syncope in patients with AD who were treated with donepezil and hospitalised for evaluation of syncope.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1170-229X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
687-94
|
pubmed:meshHeading |
pubmed-meshheading:16060718-Aged,
pubmed-meshheading:16060718-Aged, 80 and over,
pubmed-meshheading:16060718-Alzheimer Disease,
pubmed-meshheading:16060718-Cholinesterase Inhibitors,
pubmed-meshheading:16060718-Female,
pubmed-meshheading:16060718-Humans,
pubmed-meshheading:16060718-Indans,
pubmed-meshheading:16060718-Male,
pubmed-meshheading:16060718-Piperidines,
pubmed-meshheading:16060718-Syncope
|
pubmed:year |
2005
|
pubmed:articleTitle |
Causes of syncope in patients with Alzheimer's disease treated with donepezil.
|
pubmed:affiliation |
Cardiovascular Hospital of Haut-Leveque, Bordeaux-Pessac, France. Philbordier@aol.com
|
pubmed:publicationType |
Journal Article
|